Even in the most successful startups, even many years in, the founders are dealing with hair-raising problems. They mostly conceal these struggles from the outside world and even from their own employees. There's no upside in talking about them. But I hear about them.
I am at the International Conference of Machine Learning (ICML) and will be presenting our work on Protein Language Models. If you are there and want to meet and talk about PLMs or NLP, DM me.
"You've got to be willing to fail, you've got to be willing to crash and burn - you know, with people on the phone, with starting a company, whatever. If you're afraid of failing, you won't get very far." — Steve Jobs, 1994
Amgen and @LabCentral are pleased to announce Pearl Bio and Proteinea as the winners of the 2023 Golden Ticket Competition.
We're proud to partner with LabCentral to support local biotech startups, and look forward to seeing more of Pearl Bio and Proteinea's exciting work. 🔬
Biotech leaders, here's what it takes to truly innovate. 👇
Wise words from the Founder and CEO of Flagship Pioneering, Noubar Afeyan:
"Scientific innovation is heavily limited by reasonableness.
How can you expect extraordinary results from reasonable people doing reasonable things?
Everybody's looking for extraordinary outcomes, but they constantly want to figure out whether every single step is the right, reasonable one.
People go ask key opinion leaders, they do what's called due diligence and there's this massive crowdsource reasonableness filter. And yet they expect extraordinary results...
I learned a long time ago, that if you aspire to extraordinary results, you've got to be comfortable with being unreasonable—and persistently so.
So you might say, "Well, then, if you're unreasonable, does that mean you get extraordinary results?"
Of course, not; it's not reversible...
And that's where the evolutionary approach comes in:
You first project yourself to things and places that people consider unreasonable in terms of what you're proposing to do or are willing to do...
But then what makes you survive is recognizing that when you get there, you can do variation and selection and look for what survives.
Every single company that we've created at Flagship has this exact same philosophy."
Noubar Afeyan, Flagship Pioneering
ما خسرته بالشدة كنتَ أقرب إلى كسبه باللين، وما ضيعته بالغضب كنت أقرب إلى نيله بالأدب، وما فرطت فيه بالعناد كنتَ أقرب إلى التمسك به بالتفاهم. وما ضيَّع ابنَ آدم إلا عجَلته، وما آذاه إلا قسوتُه، وما فاته جميلٌ في حياته إلا بتخلّيه عن رفقِه في الأمور كلها.
يوسف الدموكي
Introducing Ankh ☥ :
An optimized protein language model (PLM) achieving SoTA performance with < 10% of the top/closest-performing models’ parameters. It is benchmarked on various downstream protein tasks, and tested for protein generation.
https://t.co/7VYwz748TV
(1/n)
1/10
I could say I predicted this – yet another month of surging exports and flat imports – but in fact I never expected quite this much. Exports in June grew 17.9% year on year, far more than forecast, to $331 billion. That's up 7.5% month on month.
https://t.co/82BmwEImGJ
@azizelgammal presents about the #NextGen Full Stack Biomanufacturing Platform being worked on by the Proteinea Team from #Egypt.
For more on this and more #synbio projects by young African Scientists, join the African iGEM showcase event here; https://t.co/mt28BLHnYg
The very existence of your startup should ~not~ be predicated on the next round of funding
It's always been true, but finding myself repeating this a lot more lately...